Dissanayake, Dushanthi
MacDonell, Su-Yin
Devereaux, P. J.
Ke, Janny Xue Chen https://orcid.org/0000-0002-3121-9780
Article History
Received: 17 July 2025
Accepted: 13 February 2026
First Online: 25 March 2026
Declarations
:
: Not applicable, no patients involved in this editorial.
: Not applicable, no patients involved in this editorial.
: Dr. Janny Ke received salary support as the Clinical Data Lead, St. Paul’s Hospital, Vancouver, BC, Canada, for the project “Reducing Opioid Use for Pain Management” DIGITAL, Canada’s Global Innovation Cluster for digital technologies, and a project consortium (Careteam Technologies Inc, Thrive Health Inc, Excelar Technologies (Connected Displays Inc), Providence Health Care Ventures Inc, and Xerus Inc [now part of Excelar]). Dr. Ke provided paid consulting for Careflow Technologies (Connected Displays Inc), funded via Providence Health Care Ventures (Vancouver, BC, Canada). Dr. Ke received research and salary support for the investigator-led, industry funded project "The impact of enhanced postoperative vitals monitoring in-hospital and at home vs. existing intermittent in-hospital monitoring for patients undergoing inpatient abdominal and vascular surgery: A pilot two-centre randomized controlled study" (ClinicalTrials NCT06584825), funded by DIGITAL and a project consortium (Medtronic of Canada ULC, Cloud Diagnostics Canada ULC, Excelar Technologies [Connected Displays Inc.], Providence Health Care Ventures Inc, 3D Bridge Solutions Inc, and FluidAI [NERv Technology Inc.]). Dr. Devereaux has received grants to conduct studies from Abbott Diagnostics, AOP Pharma, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers-Squibb, CloudDX, Coviden, Javelin Medical Limited, Octapharma, Philips Healthcare, Roche Diagnostics, Siemens and Stryker. Dr. Devereaux has participated in advisory board meetings for GlaxoSmithKline, Boehringer Ingelheim, Bayer and Quidel Canada. He attended an expert panel meeting with AstraZeneca and Boehringer Ingelheim, and he was a consultant for Abbott Diagnostics, Astra Zeneca, Roche Canada, and Trimedic. He has also been invited as a speaker with Bayer Inc and Abbott Diagnostics.